OTC Markets OTCPK - Delayed Quote USD

The Greater Cannabis Company, Inc. (GCAN)

0.0009

-0.0001

(-10.00%)

At close: January 10 at 3:48:26 PM EST

GCAN to Explore Strategic Alternatives in Artificial Intelligence and Quantum Computing

Company today announced a major strategic step forward as it explores new growth avenuesArtificial Intelligence (AI) and Quantum Computing industries represent multi-trillion dollar market opportunities1,2Company is committed to maximize shareholder value through evaluation of strategic options BALTIMORE, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a publicly traded biopharmaceutical company pioneering development of next generation th

GlobeNewswire 10 days ago

GCAN
-10.00%
GCANRx Announces Completion of Preclinical Study for Neuropsychiatric Cannabinoid Therapy

BALTIMORE, MD, Feb. 27, 2024 (GLOBE NEWSWIRE) -- Greater Cannabis Company, Inc. (“GCANRx” or the “Company”) (OTC: GCAN) a biopharmaceutical company pioneering development of next generation cannabinoid therapeutics and consumer products today announced that it has completed the preclinical phase of assessing its novel neuropsychiatric cannabinoid therapy. The Company had previously announced the preclinical study as part of its license and research agreement with Shaare Zedek Scientific related

GlobeNewswire 10 months ago

GCAN
-10.00%

Performance Overview

Return	GCAN	S&P 500
YTD	+100.00%	-1.35%
1-Year	+12.50%	+22.51%
3-Year	-70.00%	+24.59%